3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Breast Neoplasms
26
Pain, Postoperative
17
Neoplasms
13
Lung Neoplasms
12
Brain Neoplasms
12
Depression
7
Carcinoma, Hepatocellular
7
Pain
6
Colonic Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Prostatic Neoplasms
5
Leiomyoma
5
Head and Neck Neoplasms
5
Agnosia
5
Ovarian Neoplasms
4
Multiple Myeloma
4
Delirium
4
Colorectal Neoplasms
4
Anxiety Disorders
4
Supratentorial Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Myofibroma
3
Lymphoma
3
Hemorrhage
3
Fatigue
3
Emergence Delirium
3
Chronic Pain
3
Carcinoma, Non-Small-Cell Lung
3
Interventions
ferric carboxymaltose
4
iron isomaltoside 1000
3
ferric derisomaltose
2
Iron-Dextran Complex
2
ferroglycine sulfate
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Sodium Chloride
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Niferex
1
Gastroscopy
1
Ferric Oxide, Saccharated
1
Control Groups
1
Colonoscopy
1
Colonography, Computed Tomographic
1
Betaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anemia, Iron-Deficiency
×
Saline Solution
×
Clear all
NCT05467319
2022-07-20
FORGE
Alberta Health Services, Calgary
Phase 3
Unknown
82 enrolled